Geratherm Medical AG (ETR:GME)
Germany · Delayed Price · Currency is EUR 2.090
-0.020 (-0.95%)
Oct 6, 2026, 5:35 PM CET
Geratherm Medical AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 13.86 | 14.86 | 13.98 | 20.96 | 25.85 | 23.94 |
Other Revenue | 0.11 | 0.11 | 0.22 | 0.22 | - | 0.12 |
| 13.97 | 14.98 | 14.2 | 21.18 | 25.85 | 24.06 | |
Revenue Growth | 0.75% | 5.45% | -32.93% | -18.07% | 7.45% | -12.77% |
Cost of Revenue | 4.89 | 5.88 | 8.04 | 5.11 | 10.12 | 8.79 |
Gross Profit | 9.09 | 9.09 | 6.16 | 16.07 | 15.73 | 15.26 |
Selling, General & Admin | 6.02 | 5.84 | 5.97 | 8.5 | 8.43 | 8.83 |
Other Operating Expenses | 3.26 | 3.06 | -3.05 | 3.74 | 3.55 | 4.2 |
Operating Expenses | 10.42 | 10.06 | 4.78 | 13.97 | 13.46 | 14.78 |
Operating Income | -1.33 | -0.96 | 1.38 | 2.11 | 2.26 | 0.49 |
Interest Expense | -0.07 | -0.08 | -0.11 | -0.15 | -0.18 | -0.14 |
Interest & Investment Income | 0.18 | 0.16 | 0.14 | 0.11 | 0.01 | 0.03 |
Earnings From Equity Investments | - | - | - | - | - | -0.03 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.01 | -0.11 | 0.19 | 0.1 |
Other Non Operating Income (Expenses) | 0.12 | 0.04 | 0.1 | 0.56 | 0.05 | 0.03 |
EBT Excluding Unusual Items | -1.11 | -0.86 | 1.5 | 2.51 | 2.33 | 0.47 |
Merger & Restructuring Charges | - | - | - | - | - | -0 |
Gain (Loss) on Sale of Investments | 0.1 | -0.05 | -0.53 | -0.2 | -0.75 | -0.21 |
Other Unusual Items | - | - | - | - | 0.11 | 0.03 |
Pretax Income | -1.02 | -0.91 | 0.97 | 2.31 | 1.71 | 0.31 |
Income Tax Expense | 0 | -0.08 | 0.32 | 0.65 | 0.63 | -0.03 |
Earnings From Continuing Operations | -1.02 | -0.83 | 0.65 | 1.67 | 1.08 | 0.33 |
Minority Interest in Earnings | 0.17 | 0.01 | 0.05 | -0.55 | -0.06 | -0.21 |
Net Income | -0.85 | -0.82 | 0.71 | 1.11 | 1.02 | 0.12 |
Net Income to Common | -0.85 | -0.82 | 0.71 | 1.11 | 1.02 | 0.12 |
Net Income Growth | - | - | -36.54% | 8.57% | 737.28% | -94.02% |
Shares Outstanding (Basic) | 4 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 4 | 5 | 5 | 5 | 5 | 5 |
Shares Change | -17.29% | - | - | -0.61% | 10.00% | - |
EPS (Basic) | -0.19 | -0.15 | 0.13 | 0.21 | 0.19 | 0.02 |
EPS (Diluted) | -0.19 | -0.15 | 0.13 | 0.21 | 0.19 | 0.02 |
EPS Growth | - | - | -36.54% | 9.23% | 839.80% | -95.12% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.42 | 1.14 | 1.67 | 0.71 | 0.64 | 0.18 |
Free Cash Flow Per Share | 0.09 | 0.21 | 0.31 | 0.13 | 0.12 | 0.04 |
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.100 | 0.150 | 0.120 |
Dividend Growth | 0% | 0% | 0% | -33.33% | 25.00% | -70.00% |
Gross Margin | 65.04% | 60.71% | 43.38% | 75.89% | 60.84% | 63.45% |
Operating Margin | -9.50% | -6.44% | 9.74% | 9.95% | 8.75% | 2.02% |
Profit Margin | -6.11% | -5.47% | 4.96% | 5.25% | 3.96% | 0.51% |
Free Cash Flow Margin | 3.00% | 7.63% | 11.79% | 3.37% | 2.49% | 0.74% |
EBITDA | -0.19 | 0.2 | 3.24 | 3.83 | 3.74 | 1.79 |
EBITDA Margin | -1.38% | 1.30% | 22.82% | 18.08% | 14.46% | 7.46% |
D&A For EBITDA | 1.14 | 1.16 | 1.86 | 1.72 | 1.48 | 1.31 |
EBIT | -1.33 | -0.96 | 1.38 | 2.11 | 2.26 | 0.49 |
EBIT Margin | -9.50% | -6.44% | 9.74% | 9.95% | 8.75% | 2.02% |
Effective Tax Rate | - | - | 32.58% | 27.93% | 36.82% | - |
Revenue as Reported | 15.93 | 15.92 | 18.73 | 25.74 | 27.74 | 25.87 |